Page 1

Press Release Novozymes is unlocking growth by delivering strong Q3 results and increasing full - year guidance novozymes Rethink Tomorrow Novozymes delivered 7 % organic sales growth in the third quarter and 6 % organic sales growth in the first nine months of 2021 . Due to stronger performance the company has upgraded its full year financial guidance from previously 4-6 % organic sales growth to 5-6 % and an EBIT margin of around 27 % , from previously around 26 % . COPENHAGEN , Denmark - October 27 , 2021. In the first nine months of the 2021 financial year , Novozymes delivers 6 % organic sales growth , an EBIT - margin of 28.8 % , and ROIC including goodwill of 22.1 % . This marks an important step in fulfilling Novozymes ' long - term growth strategy ' Unlocking Growth - Powered by Biotech ' . " Our results for the first nine months are strong , and I am proud to say that we deliver double - digit organic sales growth in three of our five business areas . Novozymes is built for growth and we are very pleased to upgrade our full - year outlook to 5-6 % organic sales growth . We focus on driving our strategy ' Unlocking Growth - Powered by Biotech ' forward while executing and delivering on our short - term targets . We continue to deliver good performance , especially in the emerging markets , and I also want to highlight our strong performance in Food & Beverages and Human Health , " says Ester Baiget , President & CEO and continues : " There is a growing demand for our biological solutions and the investments we're making now will allow for strong long - term growth and enhanced sustainability impact worldwide . We define our priorities among the available opportunities to maximize the return on investments , while always having a clear sustainability mindset in everything we do . Our results so far clearly show that we are headed in the right direction . " Novozymes has launched eight products within the first nine months of the year , four of which were launched in the third quarter . The third quarter launches included the game - changing detergent Pristine® for Freshness to the broad markets . Business area results For the first nine months of the year , organic performance by business area were 0 % in Household Care , 15 % in Food , Beverages & Human Health , 12 % in Bioenergy , 12 % in Grain & Tech Processing , -3 % in Agriculture , Animal Health & Nutrition . While Household Care experienced soft performance in Europe , the business area did see recovery in the third quarter with 3 % organic sales growth . The Freshness platform and emerging markets contributed positively and according to expectations . The decline in Agriculture , Animal Health & Nutrition had been expected and was mainly due to a negative base effect from last year's DKK ~ 60 million one - off related to the former BioAg setup . Third - quarter sales grew 16 % organically . Regional results For the first half of the year , organic growth rates by geography were 2 % in Europe , Middle East & Africa , 2 % in North America , 12 % in Asia Pacific , and 31 % in Latin America . Sales in emerging markets grew 20 % organically and developed markets were flat . The strong performance in emerging markets was broad - based with all five business areas growing organically on top of a low - single - digit growth comparator from last year . Upgraded financial guidance for 2021 Novozymes is now guiding for 5-6 % organic sales growth for 2021 , with sales in reported DKK roughly on par with the organic sales growth , and an increased EBIT margin from previously -26 % to around 27 % . ROIC incl . goodwill is upped and now expected at 20-21 % and FCF before acquisitions is upped to DKK 2.8-3.2 billion . Novozymes A / S , Krogshoejvej 36 , 2880 Bagsvaerd , Denmark www.novozymes.com